Fernando Alonso-Sanchez

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration.

Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration.

Journal: The Journal of rheumatology

Published: June 15, 2026

Overall and sex-specific predictors of secukinumab effectiveness in European patients with psoriatic arthritis: results from the EuroSpA collaboration.

Overall and sex-specific predictors of secukinumab effectiveness in European patients with psoriatic arthritis: results from the EuroSpA collaboration.

Journal: The Journal of rheumatology

Published: June 15, 2026

Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries.

Influence of national socioeconomic status on treatment retention and disease activity in psoriatic arthritis and axial spondyloarthritis: evidence over 2 years in 13 European countries.

Journal: Annals of the rheumatic diseases

Published: February 11, 2026

Disease activity and hyperuricemia predict the development of cardiovascular events in patients with Psoriatic Arthritis: results of the 10-year prospective evaluation in the CARMA cohort.

Disease activity and hyperuricemia predict the development of cardiovascular events in patients with Psoriatic Arthritis: results of the 10-year prospective evaluation in the CARMA cohort.

Journal: Seminars in arthritis and rheumatism

Published: October 12, 2025

Giant cell arteritis-polymyalgia rheumatica spectrum disease (GPSD): Relation with neoplasms and possible role as a paraneoplastic syndrome.

Giant cell arteritis-polymyalgia rheumatica spectrum disease (GPSD): Relation with neoplasms and possible role as a paraneoplastic syndrome.

Journal: Reumatologia clinica

Published: September 13, 2025

Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry.

Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry.

Journal: Rheumatology (Oxford, England)

Published: July 22, 2025

Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry.

Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry.

Journal: Rheumatology (Oxford, England)

Published: July 14, 2025

Methodological Rationale and Insights in 'Cancer Risk in Sjögren's Disease: A Longitudinal Cohort Study on Incidence, Predictors, and Mortality Impact.

Methodological Rationale and Insights in 'Cancer Risk in Sjögren's Disease: A Longitudinal Cohort Study on Incidence, Predictors, and Mortality Impact.

Journal: Seminars in arthritis and rheumatism

Published: June 30, 2025

High incidence of lymphoma in Sjögren's disease: predictors and mortality implications in a prospective cohort study.

High incidence of lymphoma in Sjögren's disease: predictors and mortality implications in a prospective cohort study.

Journal: Rheumatology international

Published: May 28, 2025

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort.

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort.

Journal: Seminars in arthritis and rheumatism

Published: May 01, 2025

Cancer risk in Sjögren's disease: A longitudinal cohort study on incidence, predictors, and mortality impact.

Cancer risk in Sjögren's disease: A longitudinal cohort study on incidence, predictors, and mortality impact.

Journal: Seminars in arthritis and rheumatism

Published: March 12, 2025

Long-term changes in Sjögren's disease: a 9-year prospective follow-up study from the SJOGRENSER Registry.

Long-term changes in Sjögren's disease: a 9-year prospective follow-up study from the SJOGRENSER Registry.

Journal: Rheumatology international

Published: March 08, 2025

Showing 1-12 of 70

Last Updated: 09/26/2026